1. Home
  2. SNY vs SLNH Comparison

SNY vs SLNH Comparison

Compare SNY & SLNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • SLNH
  • Stock Information
  • Founded
  • SNY 1994
  • SLNH 1961
  • Country
  • SNY France
  • SLNH United States
  • Employees
  • SNY N/A
  • SLNH N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • SLNH EDP Services
  • Sector
  • SNY Health Care
  • SLNH Technology
  • Exchange
  • SNY Nasdaq
  • SLNH Nasdaq
  • Market Cap
  • SNY 123.6B
  • SLNH 6.9M
  • IPO Year
  • SNY N/A
  • SLNH N/A
  • Fundamental
  • Price
  • SNY $53.63
  • SLNH $0.84
  • Analyst Decision
  • SNY Buy
  • SLNH
  • Analyst Count
  • SNY 2
  • SLNH 0
  • Target Price
  • SNY $62.50
  • SLNH N/A
  • AVG Volume (30 Days)
  • SNY 3.4M
  • SLNH 501.5K
  • Earning Date
  • SNY 04-24-2025
  • SLNH 05-15-2025
  • Dividend Yield
  • SNY 3.00%
  • SLNH N/A
  • EPS Growth
  • SNY 2.94
  • SLNH N/A
  • EPS
  • SNY 5.45
  • SLNH N/A
  • Revenue
  • SNY $48,817,552,946.00
  • SLNH $38,021,000.00
  • Revenue This Year
  • SNY $5.35
  • SLNH N/A
  • Revenue Next Year
  • SNY $6.69
  • SLNH N/A
  • P/E Ratio
  • SNY $9.82
  • SLNH N/A
  • Revenue Growth
  • SNY 7.73
  • SLNH 80.48
  • 52 Week Low
  • SNY $45.80
  • SLNH $0.36
  • 52 Week High
  • SNY $60.12
  • SLNH $8.80
  • Technical
  • Relative Strength Index (RSI)
  • SNY 50.20
  • SLNH 54.34
  • Support Level
  • SNY $50.46
  • SLNH $0.38
  • Resistance Level
  • SNY $51.64
  • SLNH $0.87
  • Average True Range (ATR)
  • SNY 1.60
  • SLNH 0.12
  • MACD
  • SNY 0.15
  • SLNH 0.06
  • Stochastic Oscillator
  • SNY 65.92
  • SLNH 93.51

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About SLNH Soluna Holdings Inc.

Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.

Share on Social Networks: